Gland Pharma share news, announcements and annual reports
NSE: GLANDBSE: 543245Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹3,049.00.
29 Oct: open ₹3,060.00, high ₹3,111.20, low ₹3,011.00
- Next results date: the board meets on 6 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹50,733 Cr261st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.94
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.90
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.65%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,86,09368.5% delivered
Gland Pharma share news and announcements
548 announcements, routine notices left out, newest first. Page 4 of 11.
Feb 2025
3 Feb · Board meeting
3 Feb · Results
Jan 2025
18 Jan · Updates
16 Jan · Analysts
16 Jan · Board meeting
16 Jan · Updates
15 Jan · Management
Dec 2024
25 Dec · Updates
13 Dec · Analysts
9 Dec · Meeting
3 Dec · Management
3 Dec · Analysts
Nov 2024
25 Nov · Analysts
8 Nov · Meeting
8 Nov · Analysts
6 Nov · Analysts
4 Nov · Management
4 Nov · Board meeting
4 Nov · Results
Oct 2024
22 Oct · Analysts
22 Oct · Board meeting
18 Oct · Management
Sep 2024
16 Sep · Analysts
12 Sep · Analysts
10 Sep · Management
9 Sep · Analysts
6 Sep · Analysts
Aug 2024
30 Aug · Analysts
30 Aug · Management
30 Aug · Meeting
26 Aug · Analysts
16 Aug · Analysts
12 Aug · Management
8 Aug · Analysts
7 Aug · Updates
6 Aug · Board meeting
6 Aug · Results
Jul 2024